Our study identifies KAT14 as a critical epigenetic regulator of placental spiral artery remodeling involved in preeclampsia. These findings provide novel mechanistic insights into the disease pathogenesis and identify KAT14 as a potential therapeutic target.
Ma et al. (Mon,) studied this question.